Alzheimer's disease

The Alzheimer's disease research field has been beset by failed clinical trials and fraud. But researchers remain hopeful that a better understanding of the disease’s broader picture will lead to treatments.

Accuracy doesn’t only apply to isolated facts, but to the overall picture they paint.  

Exercise-induced molecules may inspire the next generation of neuroprotective drugs.

A new analysis shows huge variation in mutations for induced pluripotent stem cells, including some changes that can severely limit their ability to transform into other kinds of cells.

A once fringe theory that viral and bacterial infections trigger the neuroinflammation and cognitive decline associated with Alzheimer’s disease is gaining traction. If it proves true, available antimicrobials could be a long sought-after treatment for this neurodegenerative disease.

Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.

Spending an hour every day listening to a low-pitched thrum and gazing at blinking lights may help prevent structural changes in the brain and cognitive impairments associated with Alzheimer’s disease.

LIVE June 17th, 2021 at 2:30 PM ET
This webinar will discuss recent disease and drug discoveries enabled through screening CRISPR-modified stem cells.

University of Arizona researcher looks beyond traditional causes to find novel therapies